Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonin in affective disorders.

D G Grahame-Smith1

  • 1Radcliffe Infirmary, Oxford, UK.

International Clinical Psychopharmacology
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Serotonin (5-hydroxytryptamine; 5-HT) signaling is crucial in the brain. Reduced 5-HT function is linked to depression, and treatments affecting 5-HT show efficacy in mood disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smithkline Beecham Prize for Young Psychopharmacologists: A review of the relationship between calcium channels and psychiatric disorders.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Digoxin therapy: textbooks, theory and practice.

British journal of clinical pharmacology·2012
Same author

Altered distribution of digoxin in renal failure--a cause of digoxin toxicity?

British journal of clinical pharmacology·2012
Same author

The effect of metergoline on endocrine responses to L-tryptophan.

Journal of psychopharmacology (Oxford, England)·2011
Same author

Differential effects of lithium on agonist-stimulated inositol polyphosphate formation in rat cerebral cortex slices: Selective actions on muscarinic cholinergic responses.

Neurochemistry international·2010
Same author

Autoradiographic localization of 5-HT(3) receptor ligand binding in the cat brainstem.

Neurochemistry international·2010
Same journal

Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.

International clinical psychopharmacology·2026
Same journal

Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.

International clinical psychopharmacology·2026
Same journal

Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).

International clinical psychopharmacology·2026
Same journal

Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.

International clinical psychopharmacology·2026
Same journal

Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

International clinical psychopharmacology·2026
Same journal

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Serotonin (5-hydroxytryptamine; 5-HT) is a key neurotransmitter in the central nervous system.
  • Evidence suggests reduced 5-HT synthesis or function in depressed patients.
  • Effective treatments for affective disorders impact 5-HT function.

Purpose of the Study:

  • To explore the complex role of serotonin in brain function.
  • To examine how various treatments for affective disorders influence 5-HT systems.
  • To understand the implications of 5-HT modulation for psychological and emotional well-being.

Main Methods:

  • Review of biochemical, pharmacological, and neuroendocrine studies.
  • Analysis of animal and human evidence on 5-HT function.

Related Experiment Videos

  • Examination of the effects of selective serotonin reuptake inhibitors (SSRIs) and other psychotropic agents.

    • Main Results:

    • 5-HT function is intricate, involving multiple receptor subtypes and widespread neuronal projections.
    • Drugs like paroxetine selectively inhibit 5-HT reuptake, affecting 5-HT systems and interacting neurotransmitters.
    • Various treatments, including SSRIs, MAOIs, lithium, and ECT, modulate 5-HT function differently but are effective in affective illnesses.

    Conclusions:

    • Serotonin plays a significant role in mood regulation and various brain functions.
    • Modulation of 5-HT systems is a common mechanism underlying the efficacy of treatments for affective disorders.
    • Further research into 5-HT pathways can yield insights into novel therapeutic strategies.